Lv31
348 积分 2023-10-12 加入
Blinatumomab, a Bispecific T-cell Engager (BiTE®) for CD-19 Targeted Cancer Immunotherapy: Clinical Pharmacology and Its Implications
6小时前
待确认
Tumor Regression in Cancer Patients by Very Low Doses of a T Cell–Engaging Antibody
6小时前
已完结
The kinetics of endosomal disruption reveal differences in lipid nanoparticle induced cellular toxicity
1个月前
已完结
Albumin-recruiting lipid nanoparticle potentiates the safety and efficacy of mRNA vaccines by avoiding liver accumulation
1个月前
已完结
Chemistry, manufacturing and controls strategies for using novel excipients in lipid nanoparticles
3个月前
已完结
Engineered multi-domain lipid nanoparticles for targeted delivery
3个月前
已完结
Non-liver mRNA Delivery
3个月前
已完结
Strategies to reduce the risks of mRNA drug and vaccine toxicity
3个月前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
3个月前
已完结
Targeting cancer with mRNA–lipid nanoparticles: key considerations and future prospects
3个月前
已完结
皖公网安备34019202002308
